Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.

Thrombosis and haemostasis - 1 Dec 2010

Frontroth Juan Pablo, Hepner Mirta, Sciuccati Gabriela, Feliú Torres Aurora, Pieroni Graciela, Bonduel Mariana

Abstract excerpt

Type 2B von Willebrand disease (VWD2B) and platelet-type von Willebrand disease (PT-VWD) are rare bleeding disorders characterised by an increased ristocetin-induced platelet aggregation (RIPA) at low dose of ristocetin. It was the objective of this study to detect children with VWD2B and PT-VWD using RIPA at low dose of ristocetin (0.5 mg/ml) in the screening evaluation of bleeding disorders, and to analyse the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Argentina
Share to Blood Coagulation Tests

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enzyme-Linked Immunosorbent Assay

Share to Platelet Aggregation

Share to Platelet Function Tests

Share to von Willebrand Disease, Type 2

Share to von Willebrand Diseases

Share to von Willebrand Factor

Source

Identifiers

PMID: 20941465
DOI: 10.1160/TH10-04-0213

Genes

VWF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prospective study of low-dose ristocetin-induced platelet aggregation to identify type 2B von Willebrand disease (VWD) and platelet-type VWD in children.PMID 20941465Read ↗

A family having type 2B von Willebrand disease with a novel VWF p.R1308S mutation: Detection of characteristic platelet aggregates on peripheral blood smears as the key aspect of diagnosis.Semantic proximity Read ↗

Platelet-type von Willebrand disease: a rare, often misdiagnosed and underdiagnosed bleeding disorder.Semantic proximity Read ↗

Evaluation of an heterogeneous group of patients with von Willebrand disease using an assay alternative to ristocetin induced platelet agglutination.Semantic proximity Read ↗

Phenotypic Parameters in Genotypically Selected Type 2B von Willebrand Disease Patients: A Large, Single-Center Experience Including a New Novel Mutation.Semantic proximity Read ↗

A Short History of Diagnostic Tests for von Willebrand Disease: In Memory of Barry Firkin (1930 to 2001) and Ted Zimmerman (1937 to 1988)Semantic proximity Read ↗

Diagnosis of inherited von Willebrand disease: a clinical perspective.Semantic proximity Read ↗

A type 2b von Willebrand disease mutation (Ile546-->Val) associated with an unusual phenotype.Semantic proximity Read ↗

Type 2B von Willebrand Disease: A Matter of Plasma Plus Platelet Abnormality.Semantic proximity Read ↗

Identification of p.W246L as a novel mutation in the GP1BA gene responsible for platelet-type von Willebrand disease.Semantic proximity Read ↗

Type 2B von Willebrand Disease: Early Manifestation as Neonatal Thrombocytopenia.Semantic proximity Read ↗

Type 2B von Willebrand's disease due to Val1316Met mutation. Heterogeneity in the same sibship.Semantic proximity Read ↗

Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.